Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1026

1.

Eighteen months of drug treatment for depression: predicting relapse and recovery.

Mulder RT, Frampton CM, Luty SE, Joyce PR.

J Affect Disord. 2009 Apr;114(1-3):263-70. doi: 10.1016/j.jad.2008.08.002. Epub 2008 Sep 20.

PMID:
18805590
2.

The relationship of personality disorders to treatment outcome in depressed outpatients.

Mulder RT, Joyce PR, Luty SE.

J Clin Psychiatry. 2003 Mar;64(3):259-64.

PMID:
12716266
3.

How long should patients with psychotic depression stay on the antipsychotic medication?

Rothschild AJ, Duval SE.

J Clin Psychiatry. 2003 Apr;64(4):390-6.

PMID:
12716238
4.

Residual symptoms in depressed patients who respond acutely to fluoxetine.

Nierenberg AA, Keefe BR, Leslie VC, Alpert JE, Pava JA, Worthington JJ 3rd, Rosenbaum JF, Fava M.

J Clin Psychiatry. 1999 Apr;60(4):221-5.

PMID:
10221281
5.
6.

Relapse in patients on long-term fluoxetine treatment: response to increased fluoxetine dose.

Fava M, Rappe SM, Pava JA, Nierenberg AA, Alpert JE, Rosenbaum JF.

J Clin Psychiatry. 1995 Feb;56(2):52-5.

PMID:
7852252
7.

Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder.

Perlis RH, Nierenberg AA, Alpert JE, Pava J, Matthews JD, Buchin J, Sickinger AH, Fava M.

J Clin Psychopharmacol. 2002 Oct;22(5):474-80.

PMID:
12352270
8.

Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up.

Narushima K, Kosier JT, Robinson RG.

J Nerv Ment Dis. 2002 May;190(5):296-303.

PMID:
12011609
9.

A randomized trial of relapse prevention of depression in primary care.

Katon W, Rutter C, Ludman EJ, Von Korff M, Lin E, Simon G, Bush T, Walker E, Un├╝tzer J.

Arch Gen Psychiatry. 2001 Mar;58(3):241-7.

PMID:
11231831
10.

Executive dysfunction and long-term outcomes of geriatric depression.

Alexopoulos GS, Meyers BS, Young RC, Kalayam B, Kakuma T, Gabrielle M, Sirey JA, Hull J.

Arch Gen Psychiatry. 2000 Mar;57(3):285-90.

PMID:
10711915
11.

Factors affecting return of symptoms 1 year after treatment in a 62-week controlled study of fluoxetine in major depression.

Reimherr FW, Strong RE, Marchant BK, Hedges DW, Wender PH.

J Clin Psychiatry. 2001;62 Suppl 22:16-23.

12.

Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression.

McGrath PJ, Stewart JW, Petkova E, Quitkin FM, Amsterdam JD, Fawcett J, Reimherr FW, Rosenbaum JF, Beasley CM Jr.

J Clin Psychiatry. 2000 Jul;61(7):518-24.

PMID:
10937611
13.

Personality disorder comorbidity with major depression and response to fluoxetine treatment.

Fava M, Bouffides E, Pava JA, McCarthy MK, Steingard RJ, Rosenbaum JF.

Psychother Psychosom. 1994;62(3-4):160-7.

PMID:
7846259
14.

Predictors of early recovery from major depression among persons admitted to community-based clinics: an observational study.

Meyers BS, Sirey JA, Bruce M, Hamilton M, Raue P, Friedman SJ, Rickey C, Kakuma T, Carroll MK, Kiosses D, Alexopoulos G.

Arch Gen Psychiatry. 2002 Aug;59(8):729-35.

PMID:
12150649
15.

Two-year maintenance treatment with citalopram, 20 mg, in unipolar subjects with high recurrence rate.

Franchini L, Zanardi R, Gasperini M, Smeraldi E.

J Clin Psychiatry. 1999 Dec;60(12):861-5.

PMID:
10665634
16.
17.

Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo.

Stewart JW, Quitkin FM, McGrath PJ, Amsterdam J, Fava M, Fawcett J, Reimherr F, Rosenbaum J, Beasley C, Roback P.

Arch Gen Psychiatry. 1998 Apr;55(4):334-43.

PMID:
9554429
18.

Prevention of relapse in residual depression by cognitive therapy: a controlled trial.

Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R, Jenaway A, Cornwall PL, Hayhurst H, Abbott R, Pope M.

Arch Gen Psychiatry. 1999 Sep;56(9):829-35.

PMID:
12884889
19.

Switching versus augmentation: a prospective, naturalistic comparison in depressed, treatment-resistant patients.

Posternak MA, Zimmerman M.

J Clin Psychiatry. 2001 Feb;62(2):135-42; quiz 143.

PMID:
11247104
20.

Residual symptoms in depressed patients after treatment with fluoxetine or reboxetine.

Nelson JC, Portera L, Leon AC.

J Clin Psychiatry. 2005 Nov;66(11):1409-14.

PMID:
16420078

Supplemental Content

Support Center